Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 35.20

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (80)	12/17/2002 5:23:43 PM
From: keokalani'nui	Read Replies (1) of 566

This one is one big disappointment. (Isn't the allergy drug in P1 in UK, right, or only filed to start?) This is also a case of not knowing what's going on inside being bad for your financial health--shares same trait with dddp. I would sure like to see the cancer and Hep C drugs move forward. OT. I don't know about you, but I think the medi ac decision is bad for idbe, though the stock hasn't responded that way AH. Plus, if flumist wan't effective in any given population, good luck to fluinsure (actually I should read the briefing report before saying that). Consider idbe as a short? How about another, AVII, as a combo cancer-vaccine and antisense loser? What am I so glum?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next